Massachusetts General Hospital in Boston to test Planmed Verity® Extremity Scanner

Press release

A research collaboration between the Massachusetts General Hospital (Boston, MA) and Finnish Planmed Oy is studying the benefits and value of 3D imaging options of CBCT technology for imaging of extremities. The Planmed Verity® Extremity Scanner was installed in the Massachusetts General Hospital (MGH) in Boston in February, and the objective of this research project is to investigate the feasibility of this device in various applications. In addition, the image quality, speed of examination, and accuracy of diagnosis of this new device is being assessed in relation to traditional CT equipment.

“Planmed is actively involved in a wide variety of important research projects concerning both of our product lines: mammography and breast cancer detection as well as orthopedic imaging. We are keen to receive feedback and comparison data for our newest product, Planmed Verity® Extremity Scanner”, says Mr Vesa Mattila of Planmed Oy.

Planmed Verity® is designed to find subtle extremity fractures at the first visit to the clinic – fractures that have been the most commonly missed using only 2D radiographs. Planmed Verity is a unique solution to the problem with fast 3D imaging at the point of care. It is intended for pre- and postoperative imaging with better resolution, patient adaptability, and significantly lower dose than full-body CTs. Unlike any other 3D imaging device, Planmed Verity also allows weight-bearing imaging of the extremities.

As a dedicated extremity scanner, the mobile Planmed Verity adapts to the patient with anatomy-specific imaging programs, movements, and trays. Easily adjustable, soft surfaced gantry and motorized positioning trays help in finding a comfortable position for various examination procedures. The adjustable user interfaces and efficient all-in-one workflow are also designed to maximize the operator’s soothing presence for the patient.

Planmed Verity has a CE mark and is available for sale in the EU and many other countries where the CE certificate permits sales. FDA approval is pending.

Planmed Oy and the Planmeca Group
Planmed Oy develops, manufactures, and markets advanced imaging equipment and accessories for mammography and orthopedic imaging. Planmed's extensive mammography product range covers digital and analog units, stereotactic biopsy devices, and breast positioning systems for an early detection of breast cancer. Within orthopedic 3D imaging Planmed offers low dose extremity CT imaging for quicker, easier and more accurate diagnosis at the point-of-care.
Planmed Oy exports more than 98% of its production to over 70 countries worldwide. The principal markets are Europe, Asia as well as North and Latin America where the company has considerable market shares. Planmed Oy is part of the Finland-based Planmeca Group which manufactures and markets advanced equipment for medical and dental fields. The Group employs approximately 2,400 professionals and the estimated turnover for the year 2012 is MEUR 750.